Skip to main content
. 2020 May 27;6(22):eaba3167. doi: 10.1126/sciadv.aba3167

Fig. 1. Schematic illustration of lung-targeted programmed MOMC/PER therapeutic designed to reverse IPF.

Fig. 1

(A) Bioconjugated MOMC/PER was prepared by incubating PER NPs with MOMC. (B) MOMC/PER has multifunctional moieties including a homing moiety, responsive release moiety, and retargeting moiety to reverse IPF. Then, a weeding and uprooting strategy contributes to IPF reversion. (C) Schematic illustration of MOMC/PER for improved drugs accumulation and antifibrotic effect in IPF lung microenvironment.